The "Mar-A-Lago Accord" Is Now Underway

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

SoundHound AI Stock Is Surging: What's Going On?

Evette Mitkov
October 02, 2025

SoundHound AI Inc (NASDAQ:SOUN) shares are trading sharply higher Thursday. The stock may be benefiting from renewed investor attention to the company’s recent industry recognition and strong revenue momentum.

What To Know: SoundHound was recently positioned as a Leader in IDC MarketScape’s Worldwide General-Purpose Conversational AI Platforms 2025 Vendor Assessment, released in September. The research firm evaluated vendors on customer satisfaction, functionality and innovation, with SoundHound receiving praise for its Amelia platform’s ability to handle complex requests and deliver natural voice interactions.

“SoundHound is delivering a strong offering that is winning praise from customers for its accurate intent recognition, even for complex requests, combined with superior voice channel capabilities,” said Hayley Sutherland, research manager for Conversational AI at IDC.

The company has demonstrated significant business momentum, repeatedly raising its fiscal 2025 revenue guidance. Most recently, SoundHound lifted its full-year revenue guidance to a range of $160 million to $178 million. The acceleration comes as SoundHound builds out its enterprise customer base and expands its conversational AI offerings.

Analysts maintain a consensus price target of $12.63 on the stock, with bulls pointing to the company’s strong backlog and long-term growth rate as key drivers. The company’s Amelia 7 platform, launched in May, was among the first to offer agentic AI capabilities for enterprise use.

SOUN Analysis: Benzinga Edge rankings highlight strong momentum for SoundHound, assigning it a score of 96.55 -- a clear indication of bullish tailwinds, according to Benzinga data. The stock's price action confirms the trend, marked by a consistent pattern of higher highs and higher lows.

Volume is robust with 56 million shares exchanging hands on Thursday as of the time of writing, suggesting strong interest and participation in the current move. Support is established at $16.45, providing a solid base for any pullbacks. Resistance is noted at $18.06, where the stock has faced selling pressure previously.

The RSI is calculated at 70.12, indicating the stock is nearing overbought territory, which could signal a potential pullback. The MACD shows bullish momentum, but the lines are converging, suggesting a possible slowdown in the current trend.

SOUN Price Action: SoundHound AI shares were up 10.79% at $17.89 at the time of publication on Thursday, according to Benzinga Pro.

Read Next:

  • Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday

Image: Tigarto/Shutterstock

Continue Reading...

Popular

Nebius Vs. Palantir: The AI Infrastructure War At 100x Sales

Wall Street's AI mania has sparked a battle between Nebius (NBIS) and Palantir (PLTR) as investors question where the true value of AI lies.

FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite

FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.

Want To Know the No.1 Crypto and the No.1 Stock? - Ad

The #1 crypto is just $3. Crypto analysts say a cash injection could drive it as high as $100 in the next year. The #1 stock is equally exciting. It's less than $10 but made a HUGE deal recently to work with Nvidia.

Cardlytics Stock Surges 5% After Hours As Citron Research Spotlights Wells Fargo Partnership

Cardlytics Inc. (NASDAQ: CDLX) saw its stock fall 9.85% during regular trading on Thursday. However, the stock rebounded in after-hours trading, climbing 5.04% to $2.50 following positive remarks from analysts.

Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead

Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

America Has A New No. 1 Beer — And It's Got Bud Light DNA

When it comes to beer in the United States, there's a new bestselling brand.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Bitcoin Struggles Around $112,000, But Here's Why The Bull Run Is Not Over Yet

Bitcoin's (CRYPTO: BTC) is languishing around $112,000, but a prominent trader remains adamant about a strong end to the year.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Ethereum Co-Founder Vitalik Buterin Responds to Security Concerns Over OpenAI's ChatGPT

Ethereum co-founder Vitalik Buterin has voiced his concerns over potential security risks associated with OpenAI's ChatGPT, which could lead to the leakage of personal user data.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

BlackRock Turns Popular Mutual Funds Into Global Equity ETFs

BlackRock turns two top mutual funds into active ETFs, giving investors global equity exposure and strategies to manage volatility.

Carney Cuts The Red Tape, Unveils Over $43 Billion In Flagship Projects

PM Mark Carney announces first projects to be reviewed by Canada's new Major Projects Office, aiming to cut red tape and attract investments.

Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad

If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."

Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.

AstraZeneca's Fasenra Falls Short In Smoker's Lung Trial

AstraZeneca's Fasenra misses the primary COPD endpoint while Saphnelo's lupus trial shows significant improvements and consistent safety profiles.

How the Multiplier Effect is Working on This $3 Crypto - Ad

It's called the multiplier effect in crypto. In short, because of a lack of supply, small inflows of cash can create major moves in the overall value of the crypto. And it's particularly strong in one $3 crypto. Crypto analysts are suggesting it could rise to as high as $100 by next year.

Fed convenes meeting with a governor newly appointed by Trump and another he wants to oust

WASHINGTON (AP) — After a and the Federal Reserve began a key meeting on interest rate policy Tuesday with both a new Trump administration appointee and an official the White House has targeted for removal.

Asian shares retreat after Intel helped drive Wall Street to more records

MANILA, Philippines (AP) — Asian shares mostly retreated Friday after a rally of technology stocks led by Nvidia and Intel

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

Scam centers are spreading in East Timor, UN report says

BANGKOK (AP) — A suspected scam call operation and a suspicious network of companies was discovered with links to a new free trade zone in East Timor, the U.N. Office of Drugs and Crime said Thursday.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'

Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.

Microsoft resolves European Union probe into Teams

LONDON (AP) — European Union regulators have accepted Microsoft's to Teams, resolving a long-running antitrust investigation that targeted the company's messaging and videoconferencing app.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI

This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.

No casino in Manhattan after community board rejects proposed Mohegan Sun resort near United Nations

NEW YORK (AP) — There will be no casino in Manhattan after a community panel rejected a proposed Mohegan Sun resort near the United Nations headquarters.

Want To Know the No.1 Crypto and the No.1 Stock? - Ad

The #1 crypto is just $3. Crypto analysts say a cash injection could drive it as high as $100 in the next year. The #1 stock is equally exciting. It's less than $10 but made a HUGE deal recently to work with Nvidia.

Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO

The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).

Long-wrought WTO agreement aimed at reducing overfishing takes effect

GENEVA (AP) — A World Trade Organization agreement aimed at reducing took effect Monday, requiring countries to reduce subsidies doled out to fishing fleets and aiming to ensure sustainability of wildlife in the world's seas and oceans.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Ticket marketplace StubHub to see if its stock is the right price for Wall Street

NEW YORK (AP) — StubHub is set to enter the public arena Wednesday after the ticket marketplace priced its initial public offering at $23.50 per share.

What are Nexstar and Sinclair, the ABC affiliate owners who issued statements against Jimmy Kimmel

NEW YORK (AP) — spoke out against late night ahead of over comments he made about the killing of . Their comments highlight the influence local TV station owners have on national broadcasters such as Disney-owned ABC.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Workday Stock Jumps After Activist Investor Reveals $2 Billion Stake

Shares of Workday Inc. (NASDAQ:WDAY) are rising Wednesday after activist investor Elliott Investment Management revealed a $2 billion stake in the human resources technology firm, signaling strong confidence in recent moves.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service